Los Angeles Times’ Willman Wins Pulitzer Prize for Drug Exposes
Los Angeles Times reporter David Willman yesterday was awarded a Pulitzer Prize for his two-year examination of the FDA's approval of seven prescription drugs reportedly linked to the deaths of 1,000 people. Willman chronicled how the FDA approved the drugs, including Rezulin and Lotronex, "while disregarding danger signs or blunt warnings from its own specialists," and how the agency was "slow to seek withdrawals" of the drugs even after it received "reports of significant harm to patients" (Shaw, Los Angeles Times, 4/17).
This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.